Results 251 to 260 of about 168,513 (341)

The aftermath of trauma on resting state source-level MEG microstate dynamics. [PDF]

open access: yesEur J Psychotraumatol
Bertoli M   +7 more
europepmc   +1 more source

The Australia story: Current status and future challenges for the clinical applications of psychedelics

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract The past decade has seen a huge increase in clinical research with psychedelic drugs and 3,4‐methylenedioxymethamphetamine (MDMA), which have revealed great potential for treating mental health conditions. Given this progress in research, as well as the current unmet clinical need of millions of patients, in 2023, the Australian Therapeutic ...
David J Nutt   +3 more
wiley   +1 more source

Psychedelics, entactogens and psychoplastogens for depression and related disorders

open access: yesBritish Journal of Pharmacology, EarlyView.
Currently, the most actively investigated rapidly acting antidepressants, anxiolytics and/or anti PTSD agents, include psychedelics e.g. psilocybin, LSD, N,N‐dimethyltryptamine, ayahuasca; non‐hallucinogenic entactogens, e.g. MDMA; psychoplastogens which rapidly promote neuroplasticity, e.g.
Daniel Hoyer
wiley   +1 more source

Bullying victimization among adolescents during the early phase of war in Ukraine – A comparative cross‐sectional study in 2016–2017

open access: yesChild and Adolescent Mental Health, EarlyView.
Background War profoundly impacts adolescent development and may increase the likelihood of aggressive responses when such behavior is perceived as acceptable and accessible. War may, hence, exacerbate a form of interpersonal violence already prevalent among children and adolescents.
Sanju Silwal   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy